Results 221 to 230 of about 8,955,654 (340)
Technological Transitions and the Limits of Inference in Adaptive Educational Systems
H. R. Paz
openalex +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
Molecular Oncology, EarlyView.This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Indirect estimation of serum enzymes reference intervals in adults using the reflimR and refineR algorithms. [PDF]
Biochem Med (Zagreb)Yıldız R, Arslan FD, Köseoğlu M.
europepmc +1 more source
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Quality of drinking water in the United Arab Emirates: a systematic review. [PDF]
BMC Public HealthAl-Bluwi GSM +6 more
europepmc +1 more source
Entanglement Dominance in the Zero-Temperature Limit: Simulation & Theory
Javier Manuel Martín Alonso
openalex +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Molecular Oncology, EarlyView.Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source